Cite
Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: An open pilot observational study
MLA
Gabriel Bellon, et al. “Fatty Acids Platelets and Oxidative Markers Following Intravenous N-3 Fatty Acids Administration in Cystic Fibrosis: An Open Pilot Observational Study.” Journal of Cystic Fibrosis, vol. 6, Sept. 2007, pp. 320–26. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bdaed8f3810e5179beae9c87e7c04e34&authtype=sso&custid=ns315887.
APA
Gabriel Bellon, Hubert Roth, Michel Lagarde, Isabelle Durieu, Evelyne Véricel, Raphaele Nove Josserand, Jocelyne Drai, Daniel Guichardant, Jean-Paul Steghens, & Eric Fontaine. (2007). Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: An open pilot observational study. Journal of Cystic Fibrosis, 6, 320–326.
Chicago
Gabriel Bellon, Hubert Roth, Michel Lagarde, Isabelle Durieu, Evelyne Véricel, Raphaele Nove Josserand, Jocelyne Drai, Daniel Guichardant, Jean-Paul Steghens, and Eric Fontaine. 2007. “Fatty Acids Platelets and Oxidative Markers Following Intravenous N-3 Fatty Acids Administration in Cystic Fibrosis: An Open Pilot Observational Study.” Journal of Cystic Fibrosis 6 (September): 320–26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bdaed8f3810e5179beae9c87e7c04e34&authtype=sso&custid=ns315887.